Value of Comprehensive Genomic Profiling in Modern Lung Cancer Practice
Home » Value of Comprehensive Genomic Profiling in Modern Lung Cancer Practice

GH AMEA on Social Media Value of Comprehensive Genomic Profiling in Modern Lung Cancer Practice
Value of Comprehensive Genomic Profiling in Modern Lung Cancer Practice
Value of Comprehensive Genomic Profiling in Modern Lung Cancer Practice
MOSCON

Inviting all Oncologists! Register @ https://lnkd.in/gePw-3M for this 20-minute webinar session today at 7.30pm (IST) on the Value of Comprehensive Genomic Profiling in Modern Lung Cancer Practice led by Dr. Natasha B. Leighl, a distinguished medical oncologist from Canada. This is one of the highlights of the Molecular Oncology Society Conference, MOSCON 2021 which is taking place from 4th to 7th March.

Visit us online @ guardanthealthamea.com

to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at clientservices@guardantamea.com or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.

Open chat
Message us